skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi, I took a position in Open Text @$45 after release of recent quarterly results. The stock has been weak since and down 15% now. It has also not followed the general strength in the Technology sector and traded lower even when its peers KXS, CSU, DSG etc have gained in value. Analysts seem to be of view that stock is undervalued and market is not recognizing its strong recurring revenue base and expected growth from recent acquisitions.

Can you help me understand, why stock has been so weak and if a recovery is expected in next 6-12 months? I also own KXS, CSU,CGI and SYZ in Tech sector in fairly large quantities. For me it's a a question of capital allocation and find better opportunities. Thanks for your insight.
Read Answer Asked by rajeev on June 30, 2017
Q: My tech sector comprises OTEX & KXS.
KXS has done very well this past year whereas OTEX is now back where it was at that time. It seemed to be on a losing trend before it acquired COVS - which only seemed to make it worse. What's your opinion, where do you think it might be heading? Anything positive to say? Your advice very much appreciated.
Read Answer Asked by Arthur on June 29, 2017
Q: Is it possible to quantify the impact of the Nissan contract? The news release didn't include any financial details, but one would presume that Nissan's worldwide supply chain is substantial. Nissan's decision may also expose Kinaxis to an even broader international business audience. Nissan also said they "see this as a long term relationship between our two companies." I have a 1/3 position currently, as a much lower price. Also considering the recent pullback, would you step in for another 1/3 or more at this time?
Read Answer Asked by David on June 28, 2017
Q: I own equal amounts of both of these shares (1% of my portfolio).

BDSI is performing well and owns a non-opiod painkiller (BELBUCA) that just received approval from Health Canada. They need a contact in Canada to sell/distribute it. Is this the sort of thing that Knight would facilitate?

Palladin used to sell BDSI products but recently returned that portfolio to BDSI to focus on other areas. BDSI now sells directly in US.

Cam.
Read Answer Asked by Cameron on June 26, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!